Physician profile
David E Wilcox
NPI 1730155714
$16,411.22
in general payments reported to CMS, 2019-2025
7 companies · $124 in 2025
The $124 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,760 · 2020: $8,503 · 2021: $2,250 · 2022: $1,650 · 2024: $124 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $4,303.21 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $4,200.00 | 2020 | |
| Novo Nordisk INC | $3,212.00 | 2019 | |
| Pfizer INC. | $2,250.00 | 2021 | |
| Amgen INC. | $1,650.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $547.67 | 2019 | |
| Csl Behring | $248.34 | 2024-2025 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wilcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.